Mark Dybul
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS Research and Interventions 22
- HIV/AIDS drug development and treatment 7
-
- HIV, Drug Use, Sexual Risk 4
- Co-authors
- Josephine Birungi (4 shared papers)Peter Piot (8 shared papers)Edward J. Mills (4 shared papers)Timothy B. Hallett (5 shared papers)Zvi Grossman (1 shared paper)Daniel C. Douek (1 shared paper)Annette Oxenius (1 shared paper)Joseph P. Casazza (1 shared paper)
- Journals
- The Lancet (8 papers)AIDS (4 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (3 papers)PLoS ONE (3 papers)Annals of Internal Medicine (2 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Mark Dybul
36 papers receiving 3.7k citations
Mark Dybul's Hit Papers
Peers
Comparison fields: 5 of 127
- Virology 1.6k
- Infectious Diseases 2.1k
- Immunology 719
- Emergency Medicine 276
- Epidemiology 902
Countries citing papers authored by Mark Dybul
This map shows the geographic impact of Mark Dybul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dybul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dybul more than expected).
Fields of papers citing papers by Mark Dybul
This network shows the impact of papers produced by Mark Dybul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dybul. The network helps show where Mark Dybul may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Dybul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | HIV preferentially infects HIV-specific CD4+ T cells Hit paper breakdown → | 2002 | 1015 |
| 2 | 2002 | 375 | |
| 3 | 1999 | 345 | |
| 4 | 2011 | 323 | |
| 5 | 2012 | 198 | |
| 6 | 2014 | 173 | |
| 7 | 2002 | 158 | |
| 8 | 2012 | 146 | |
| 9 | 2012 | 129 | |
| 10 | 2012 | 117 | |
| 11 | 2001 | 112 | |
| 12 | 2014 | 95 | |
| 13 | 2012 | 87 | |
| 14 | 2013 | 82 | |
| 15 | 2003 | 64 | |
| 16 | 2016 | 62 | |
| 17 | 2012 | 51 | |
| 18 | 2010 | 51 | |
| 19 | 2012 | 45 | |
| 20 | 2010 | 41 |
About Mark Dybul
Mark Dybul is a scholar working on Infectious Diseases, Epidemiology, General Health Professions, Virology and Pediatrics, Perinatology and Child Health, having authored 36 papers that have together received 3.9k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (22 papers), HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (7 papers), Adolescent Sexual and Reproductive Health (5 papers), HIV, Drug Use, Sexual Risk (4 papers), Global Maternal and Child Health (3 papers), HIV-related health complications and treatments (3 papers) and Sex work and related issues (2 papers). The work is most often cited by research in Virology (1.6k citations), Infectious Diseases (2.1k citations), Immunology (719 citations), Emergency Medicine (276 citations) and Epidemiology (902 citations). Mark Dybul has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Josephine Birungi, Peter Piot, Edward J. Mills, Timothy B. Hallett, Zvi Grossman, Daniel C. Douek, Annette Oxenius, Joseph P. Casazza, Jason M. Brenchley and Mark Connors. Their work appears in journals such as The Lancet, AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, PLoS ONE and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.